15:23 EDT Novavax (NVAX) asked by FDA to complete additional COVID trial, WSJ says
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on NVAX:
- Novavax has improved clarity on path forward for Nuvaxovid, says BofA
- Unusually active option classes on open April 23rd
- Novavax’s Biologics License Application Nears Approval
- Novavax says received formal PMC request from FDA related to COVID vaccine
- Promising Results from Novavax’s SHIELD-Utah Study Boost Buy Rating Amid Vaccine Market Dynamics